Olivia Erline Gilbert

Ms. Olivia Erline Gilbert

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2022 in Medicina
Verified
Journal Article
Open access
PDF file
OGOlivia Erline Gilbert
Olivia Erline Gilbert
SLSarah E. Lawhon
Sarah E. Lawhon
TGTwila L. Gaston
Twila L. Gaston
JRJared M. Robichaux
Jared M. Robichaux
Gabriel Claudiu TenderGabriel Claudiu Tender
Gabriel Claudiu Tender
Background and Objectives: Lumbar spinal stenosis is one of the most common causes of disability in the elderly and often necessitates surgical intervention in patients over the age of 65. Our study aimed to evaluate the clinical efficacy of interlaminar stabilization following decompressive laminectomy in patients with lumbar stenosis without instability. Materials and Methods: Twenty patients with lumbar stenosis underwent decompressive laminectomy and interlaminar stabilization at our academic institution. Clinical outcomes were measured using the visual analog scale (VAS) and Oswestry disability index (ODI) at the 2-month, 6-month, and 1-year postoperative visits, and these outcomes were compared to the preoperative scores. Results: The average VAS scores for low back pain significantly improved from 8.8 preoperatively to 4.0, 3.7, and 3.9 at 2 months, 6 months, and 1 year postoperatively, respectively (p < 0.001). The average VAS scores for lower extremity pain significantly improved from 9.0 preoperatively to 2.7, 2.5, and 2.5 at 2 months, 6 months, and 1 year postoperatively, respectively (p < 0.001). The average ODI scores significantly improved from 66.6 preoperatively to 23.8, 23.3, and 24.5 at 2 months, 6 months, and 1 year postoperatively, respectively (p < 0.001). There was no statistical significance for difference in VAS or ODI scores between 2 months, 6 months, and 1 year. One patient had an intraoperative durotomy that was successfully treated with local repair and lumbar drainage. Another patient had progression of stenosis and had to undergo bilateral facetectomy and fusion. Conclusions: Decompressive laminectomy and interlaminar stabilization in patients with spinal claudication and low back pain is a good surgical option in the absence of instability and may provide significant clinical improvement of pain and functional disability.

20 August 2024 in Operative Neurosurgery
Verified
Journal Article
Closed access
OGOlivia Erline Gilbert
Olivia Erline Gilbert
KCKelly Chamberlin
Kelly Chamberlin
PGPawel Grabala
Pawel Grabala
Michael GalganoMichael Galgano
Michael Galgano

6 April 2022 in Journal of Social Distress and Homelessness
Verified
Journal Article
Open access
OGOlivia Erline Gilbert
Olivia Erline Gilbert
NDNicole A. Dominique-Branley
Nicole A. Dominique-Branley
AMAbrania Marrero
Abrania Marrero
MSMelinda S. Sothern
Melinda S. Sothern
SJStephen Phillippi Jr.
Stephen Phillippi Jr.
People experiencing homelessness encounter barriers to self-directed community health resource use that may limit autonomous decision-making. Tailored educational material is needed to increase knowledge, promote well-informed resource access, and improve community health system navigability. This study aimed to 1) assess homeless individuals' baseline knowledge and utilization of community health resources and 2) evaluate use of a pocket-sized resource guide. Participants (N = 103) were recruited at a no-cost medical clinic in New Orleans to complete pre- and post-surveys assessing knowledge and utilization of community health resources listed on the guide. Over a third (38.8%) of participants indicated having low knowledge of resources at baseline. Utilization of resources varied substantially, ranging from a majority (66.7%) to a select few (6.9%) participants reporting attendance at sites. Among participants who completed the follow-up survey, self-rated knowledge of resources significantly increased (p = 0.029); however, the number of resources used in the past month slightly declined. These results may speak to participants who used the resource guides having an improved ability to selectively access resources for their specific needs. Interventions to improve health resource knowledge can, thus, aid more efficient and autonomous decision-making and are needed to improve community health system accessibility for populations experiencing homelessness.

8 November 2021 in Pediatric Neurosurgery
Verified
Journal Article
Closed access
PDF file
OGOlivia Erline Gilbert
Olivia Erline Gilbert
JWJohn M. Wilson
John M. Wilson
JVJerome M. Volk
Jerome M. Volk
Introduction: Cavernous malformations in the pediatric population are exceedingly rare, especially in infants. Giant cavernous malformations (GCM) are even more rare and have a diameter >4 cm. The onset of symptoms predominantly occurs in adulthood, but the rate of hemorrhage is significantly higher in the pediatric population. Similar to non-GCM, GCM can be misidentified as tumors on imaging due to their tumefactive pattern with edema. Here, we present a rare case of a right frontotemporal GCM in a 2-month-old girl, the youngest recorded case in the existing literature. Case Presentation: A previously healthy 2-month-old girl presented to the emergency department following an increasing frequency of seizure-like activity that began 3 days prior to presentation. Magnetic resonance imaging of the brain with and without contrast characterized a large (5.8 × 4.3 × 4.2 cm) heterogeneous lesion of the right temporal lobe with diffuse scattered blood products of various ages seen throughout the lesion. She underwent a right-sided craniotomy where a gross total excision was achieved. Pathology confirmed the diagnoses of a GCM. The patient’s seizures subsequently resolved, and she continues to do well postoperatively. Discussion/Conclusion: GCM can be mistaken for tumors due to their large size, cystic nature, and surrounding edema, but a vascular lesion should always remain in the differential diagnosis before operating, even in infants. Surgery is generally recommended in patients that present with a symptomatic hemorrhage, recurrent hemorrhages, persistent seizures despite medical management, or progressively worsening neurological deficits if the GCM is in a safe location. It has been shown that 70–99% of patients undergoing surgery with successful removal of the GCM can achieve seizure freedom 2 years postoperatively. Complete surgical excision of this infant’s GCM was successful in treating her neurologic symptoms; therefore, pathological confirmation of this lesion is critical and should prompt a complete surgical excision.

Verified
Journal Article
Open access
PDF file
OGOlivia Erline Gilbert
Olivia Erline Gilbert
HFHenry Forbes Fowler
Henry Forbes Fowler
AMAsish Madarapu
Asish Madarapu
MRMax Reed
Max Reed
AFAli Fahim
Ali Fahim
DHDominique M. O. Higgins
Dominique M. O. Higgins
Glioblastoma (GBM) remains the most common and most aggressive primary malignant brain tumor in adults, and despite maximal safe resection with adjuvant radiotherapy (RT) and temozolomide (TMZ), median overall survival remains 12–15 months with near-universal recurrence. Ferroptosis, an iron-dependent form of regulated cell death driven by the accumulation of lipid peroxides, has emerged as a distinctive vulnerability in GBM, whose iron-avid phenotype, polyunsaturated fatty acid-rich milieu, and high oxygen consumption create a permissive substrate for lipid peroxidation. In this review, we synthesize preclinical evidence positioning ferroptosis as a determinant of GBM radiosensitivity and evaluate strategies to exploit it. We first outline core ferroptosis biology and GBM-specific modifiers of ferroptotic susceptibility, including TFR1-mediated iron import, grade-dependent glutathione peroxidase 4 (GPX4) expression, acyl-coenzyme A synthetase long-chain family member 4 (ACSL4) levels, transsulfuration, NRF2, p53, non-coding RNAs, and the relative resistance of mesenchymal tumors and glioma stem cells. We then examine mechanisms of radiation-induced ferroptosis, in which RT upregulates ACSL4 and depletes glutathione (GSH) while simultaneously provoking adaptive responses that induce the cystine transporter solute carrier family 7 member 11 (SLC7A11) and GPX4, alongside hypoxia-, IFI16/HMOX1-, and lncRNA-mediated programs that sustain radioresistance, noting that recurrent tumors display a ferroptosis-primed profile after chemoradiation. Radiosensitization strategies are reviewed across pharmacologic ferroptosis inducers (classes I-IV), repurposed agents, NRF2 inhibition, genetic targeting of ferroptosis mediators, and blood–brain barrier-penetrant nanoplatforms that couple iron delivery, high-Z radiation deposition, and antioxidant disruption. We further address the immunologic consequences of ferroptosis within the immunosuppressive GBM microenvironment, the countervailing problem of radiation-induced brain injury and candidate neuroprotective approaches, the potential convergence of FLASH RT with iron-dependent differential sparing, and comparative evidence of ferroptosis-RT synergy in other treatment-resistant malignancies. Finally, we appraise candidate biomarkers and ferroptosis-related gene signatures, and close by addressing open questions and current translational hurdles facing the field.

1 January 2026 in Ferroptosis and Oxidative Stress
Verified
Journal Article
Open access
PDF file
OGOlivia Erline Gilbert
Olivia Erline Gilbert
SJSebastian John
Sebastian John
AFAli Fahim
Ali Fahim
DHDominique M.O. Higgins
Dominique M.O. Higgins
Ferroptosis sensitivity in cancer cells is directly governed by cellular metabolism and nutritional inputs, including amino acid availability, lipid composition, and redox homeostasis. This suggests that dietary interventions might systemically shift the metabolic landscape of tumors toward ferroptotic susceptibility. Specifically, dietary restriction of methionine and cysteine, iron supplementation, selenium or lipid modulation, ketogenic diets, and fasting-mimicking regimens each target distinct aspects of the ferroptosis regulatory network and offer pharmacologic parallels that converge on complementary mechanisms. In glioblastoma (GBM), preclinical studies demonstrate that restriction of dietary methionine and cysteine sensitizes gliomas to ferroptosis and synergizes with glutathione peroxidase 4 (GPX4) inhibitors, while radiation itself triggers ferroptotic cell death. Emerging data extend these principles across multiple tumor types, including pancreatic, gastric, esophageal, and colorectal cancers, as well as leukemia, suggesting broad applicability. Here, we synthesize the rapidly growing literature that links these nutritional interventions to ferroptosis sensitization in cancer, with particular focus on GBM as a paradigmatic treatment-resistant malignancy.